The ascendancy of Viagra and its impact on the drug landscape presents a complex question for shareholders. While the initial sales data were astounding, the exclusivity has expired, leading to a deluge of off-brand https://saulimgx006262.blogsmine.com/41707133/the-blue-pill-and-big-pharma-a-risky-investment